1. The effect of deferoxamine injection on composite graft survival in rabbits
- Author
-
Rianto Noviady Ramli, Sitti Rizaliyana, Agus Santoso Budi, and Aditya Rifqi Fauzi
- Subjects
Survival rate ,PRP ,medicine.medical_specialty ,Experimental Research ,business.industry ,Urology ,General Medicine ,Deferoxamine ,Deferoxamine Injection ,Staining ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Composite graft ,030211 gastroenterology & hepatology ,Surgery ,business ,medicine.drug - Abstract
Background Composite graft as a reconstructive therapy option has limitations in size so that it is easily necrotic. Deferoxamine administration has been associated with increased neo-vascularity in wounds. We aimed to compare the administration of deferoxamine and Platelet-Rich Plasma (PRP) injection in a composite graft in rabbits. Methods Thirty New Zealand rabbits were divided into three groups; the control group, the deferoxamine group, and the PRP group. The composite graft with a diameter of 2 cm was taken and replanted after rotating it 180°. The mean graft viability and the mean number of capillaries were evaluated on day 7 (POD 7) by macroscopic and histological evaluation using Hematoxylin-Eosin staining. Results While the mean number of capillaries was not significantly different in control, deferoxamine, and PRP groups (p = 0.21), the mean survival rate in the control, deferoxamine, and PRP groups reached a significant level with p-value of 0.006 (66.6% vs. 63.8% vs. 99.6%, respectively). Conclusions Deferoxamine group had the highest number of capillaries, but had the lowest survival rate. In the PRP group, it had the lowest number of capillaries, but had the highest survival rate., Highlights • Composite grafts yield better results than skin grafts in plastic and reconstructive surgery. • The failure rate of composite graft is quite high due to limitations of re-vasculature. • The usage of deferoxamine might have a beneficial effect on increasing the graft survival.
- Published
- 2020
- Full Text
- View/download PDF